Osalmid

DB16273InvestigationalSmall molecule

Osalmid is under investigation in clinical trial NCT03670173 (Safety and Efficacy Assessments of Osalmid in Multiple Myeloma).

Mechanism: Pharmacologically active on Ribonucleoside-diphosphate reductase subunit M2
Curator reviewed
Formula / weight: C₁₃H₁₁NO₃ · 229.235 g/mol (avg)
Code names: L-1718 · NSC-93960

Resolves to

Compound

Structure

InChIKeyLGCMKPRGGJRYGM-UHFFFAOYSA-NSMILESOC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Osalmid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.